Product Details
25/BX
$ *.**
Limited QuantitiesAdditional Information
| Product Name | Tazicef 1g Vial |
| Application | Cephalosporin |
| Generic Drug Name | Ceftazidime |
| Mechanism of Action | Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) |
| Strength | 1 Gram |
| Volume | 20 mL |
| Administration Route | Intravenous or intramuscular |
| Dosing Frequency | Usually administered every 8 to 12 hours, depending on the infection |
| Onset of Action | Typically within 1 hour after intravenous administration |
| Duration of Action | 12-24 hours depending on the infection |
| Side Effects | Gastrointestinal discomfort, rash, changes in liver or kidney function |
| Special Precautions | Use with caution in patients with renal impairment |
| Drug Interactions | May interact with aminoglycosides, diuretics, and other nephrotoxic drugs |
| Primary Use | Treatment of infections caused by Gram-negative and some Gram-positive organisms, including Pseudomonas aeruginosa |
Description
Tazicef 1g vial is an injectable formulation containing the active ingredient cefoperazone, a third-generation cephalosporin antibiotic. It is indicated for the treatment of various bacterial infections, including those of the respiratory tract, urinary tract, skin and soft tissues, and intra-abdominal infections. Cefoperazone exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa.
Cefoperazone works by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis and death. It achieves this by binding to penicillin-binding proteins (PBPs) on the bacterial cell membrane, which disrupts the cross-linking of peptidoglycan chains, a crucial component of the bacterial cell wall.
The medication is administered intravenously or intramuscularly, depending on the severity and type of infection. The dosage and duration of treatment are determined based on the patient’s condition, response to therapy, and susceptibility of the infecting organisms. Healthcare providers must monitor patients for potential side effects such as gastrointestinal disturbances, allergic reactions, and alterations in liver or renal function.
Frequently Asked Questions (FAQs)
The cost of TAZICEF 1GM VIAL is $$0.00
TAZICEF 1GM VIAL is manufactured by Hospira.
You can purchase TAZICEF 1GM VIAL on our website at https://supplies.pipelinemedical.com/product/detail/tazicef-1gm-vial-417858